| 发明名称 |
Compounds for the Treatment of Hepatitis C |
| 摘要 |
The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
|
| 申请公布号 |
US2013203758(A1) |
申请公布日期 |
2013.08.08 |
| 申请号 |
US201313758624 |
申请日期 |
2013.02.04 |
| 申请人 |
BRISTOL-MYERS SQUIBB COMPANY;BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
WANG TAO;SCOLA PAUL MICHAEL;ZHANG ZHONGXING;YIN ZHIWEI;ZHAO QIAN |
| 分类号 |
C07D513/04;C07D251/52;C07D401/12;C07D401/14;C07D403/12;C07D405/12;C07D413/12;C07D417/12 |
主分类号 |
C07D513/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
